Rising Preference for Automation and Smart Technologies Drives Development of Power Tools

Constant efforts by manufacturing industries towards reducing time and manpower required for operations, is the key driver behind the rapid growth of the global power tools market, owing to the streamlining of repetitive activities in the sector, and the reduction of errors, by human hands through power tools. The production of affordable and energy-efficient tools are important factors that drive the rise of the global power tools market in the foreseeable future.

What innovations are manufacturers making to enhance the efficiency of power tools?

Power tools manufacturers are witnessing rapid growth, which is largely reliant on the inclusion of technologies that feature smart reactive operations and automation, through pneumatic or power actuated systems. Moreover, power tool producers are increasingly shifting to cordless variants of products such as saws, crimpers, and wrenches among others. This can be attributed to the preference for increased portability and improved battery technologies for longer operational time on a single charge.

Will the surging Asia Pacific construction industry influence power tool sales?

Numerous opportunities for power tools manufacturers are anticipated to emerge mainly owing to the rapid infrastructural development of cities across major emerging economies of Asia such as China and India. Moreover, China is also the largest producer of branded power tools in the worldwide market, accounting for approximately 80% of the total supply, owing to the standard low price points, which is aiding the local construction industry as well.

What are the key safety standards relevant to the production and operation of ride-on power trowels?

ISO 11148-2:2011, IEC Standards, and OSHA Certifications are a few of the many internationally respected certifications that power tools manufacturers are aiming to target in terms of compliance to raise their use in different parts of the world. Certifications from such organizations keep evolving with the development of new technologies and the need of the end use industry, influencing design and material features, along with operational guidelines for new additions to product portfolios. 

Will Lithium ion batteries play a role in shaping the future of power tools?

With the growing application of cordless power tools, an extended battery life is a key quality that manufacturers are looking to incorporate in their products. As a result, lithium-ion batteries are increasingly replacing nickel-cadmium and nickel-metal hydride batteries. This can be attributed to the smaller and lightweight properties of lithium batteries, in addition to the elimination of self-discharge, enabling storage for long durations, without power drain. Lithium ion batteries also provide better energy density increasing the efficacy and demand for power tools.

To know more? Request a Free Sample Report.

Companies Focus on Innovative Active Pharmaceutical Ingredients for Efficient Animal Healthcare

A senior analyst discusses on how innovative animal healthcare programs are benefiting the overall animal healthcare landscape.

Demand for high-protein diets has led to commercial farming of the meat and milch cattle. In developed regions such as North America, governments are taking active initiatives in controlling and preventing animal diseases, thereby, creating advisory systems for raising awareness in the general population regarding animal healthcare. Several pharmaceutical companies are increasing their focus towards animal healthcare market, catering to the surging incidences of animal disease outbreaks and hygiene management products.

How are animal healthcare programs beneficial?

On a broader perspective, with the latest animal healthcare program, an initiative by Madhya Pradesh (MP’s) Animal Husbandry Department, signing a MoU (memorandum of understanding) with BFIL (Bharat Financial Inclusion Ltd), the animal owners could avail wide-ranging veterinary services by just dialing toll-free helpline number- 1962. This animal healthcare program is likely to help the farmers, who face major issues in bringing their cattle to the animal healthcare centers.

What are some of the most recent developments in the global animal healthcare market?

Robinson Animal Healthcare, manufacturer of animal’s first-aid woundcare as well as absorbents launched an all-new Animalintex Hoof Treatment, highly beneficial in rapid treatment of the foot conditions. This new animal healthcare product is the sole VMD (Veterinary Medicines Directorate) licensed product in UK consisting of multi-layered absorbent poultice.

Colorado State University introduced a new certificate, known as Spanish for Animal Health and Care for ensuring students in animal science and veterinary fields would be equipped for communicating with the Spanish speakers in a ranch setting.

How is the trend of pet ownership taking a major leap in North America animal healthcare market?

Most of the people in U.S. own a cat or dog, which in turn increases animal expenditure especially by the millennials that are driving humanization of their furry companions. Animal healthcare is one of the most innovative and developing industries of the U.S. Animal healthcare products helps in enhancing activities in pet services, dairy and meat production, animal production and veterinary services. In addition, animal healthcare market in North America has witnessed some major M&A for attaining expertise in launching new and innovative active pharmaceutical ingredients. For example, Zoetis lately acquired Nexvet, biologic therapeutics company for introducing monoclonal antibody therapies, benefitting companion animals suffering from chronic pain.

What are some of the market strategies adopted by key companies in the animal healthcare market?

Animal healthcare manufacturers such as Neogen Corporation are taking immense efforts in acquiring animal genomics laboratory such as the one Delta Genomics Centre owns in Canada. Such acquisitions are done for enhancement of business in the particular region. Several manufacturers such as Henry Schein are planning on merging with animal healthcare businesses and start-ups, in a bid to form new companies.

In a nutshell, with increasing number of pet owners willing to make heavy payments for veterinary care, upsurge in demand for the food supplements is likely to increase at a significant rate in the animal healthcare market.

Global Animal Healthcare Market Value - By Product Type
Global Animal Healthcare Market Value – By Product Type

To get more Insights? Then request a free sample report.

Alderon, Kami LP Signs Memorandum of Understanding with Schneider Electric for Digital and Advanced Mine Operations

Alderon, the Vancouver based Mining Corporation with operations in Labrador Trough, and Kami Mine Limited Partnership have signed a joint memorandum of understanding with Schneider Electric for development funding as well as equipment acquisition for the Kami Iron Ore Project.

Alderon CEO Tayfun Eldem said that Schneider Electric was chosen owing to wide range of product and service offerings in mine digitization, process control and power and energy management. The Kami LP will harness Schneider’s expertise in providing sustainable energy solutions for optimal usage and energy costs for Kami’s Mining projects.

The collaboration is aimed at reducing equipment cost and capital spending as well as accelerating the project timeline. A September 2018 feasibility study conducted by the Kami estimated an average capital spending of $982.42 million for producing a quantity of 7.84 million tons/y of 65.2% Fe concentrate.  It also envisaged a construction period of 26 month. 

This timeline is expected to shrink to a reduced time by the use of Schneider’s EcoStruxure platform which will help Alderon in creating fully digital, efficient and advanced mine as a part of the Kami Project. The EcoStruxure platform according to the company is platform which offers world class technological solutions by using advances in IT and unlocks trapped potential in operation by harnessing the latest developments in Internet of Things.

The terms of the MoU also include Schneider Electric assisting The Kami LP in its efforts to raise funds by facilitating discussions and making introductions with potential funding sources including export credit agencies in regions where Schneider has manufacturing units. The Kami LP under the terms of the agreement have been given a free hand in choosing whether to purchase the equipment for its project or lease it.

Alderon has 75% stake in The Kami mine project in Labrador trough while HBIS Group owns about 25% of the project through Kami LP. The Kami Iron ore project is expected to have great impact on Canada’s economics by generating C$76 billion for businesses and workers creating 100,000 jobs. The project will fill government’s coffers by C$5.1 billion in federal and provincial tax revenues. The Mineral resource estimate of the project is around 12 billion tonnes at 29.8% iron and additional 522.6 million tonnes at 29.5% iron. The company has announced partnership with China’s largest steel producer HBIS Group for the Kami Project.

Alderon’s shares have surged by over 6.52% in last 12 months but traded 4% lower on 9 Jan 2018. The company is capitalized at C$33.88 million.

Baidu Announces China’s First Open Source Edge Computing Platform OpenEdge

Baidu, Chinese search giant and cloud service provider has announced launch of its open source edge computing platform OpenEdge. The announcement came at the CES 2019 event where technological giants are showcasing their might.

The platform is a first such launch in China. The company which is often dubbed as China’s Google is a pioneer in cloud computing. Edge computing is a paradigm in computing which is mostly or completely executed on distributed device nodes known as edge devices. Edge computing differs from cloud computing in the manner that the former processes data at the edge of network while the latter in a central data center or cloud. This radical new technique is gaining much mainstream attention with the growing number of Internet of Things devices and autonomous vehicles. It shifts processing power away from the cloud to the users end.

The OpenEdge platform will enable developers to build their edge computing applications and deploy them on various IoT hardware and devices. The platform which is open-sourced will simplify app development for developers. OpenEdge evolved as a part of Baidu Intelligent Edge which is a commercial software which works in tandem with Baidu Cloud. Baidu’s spokesperson Mr. Wang said that the project will empower developers to build their own edge systems as well as add more custom edge apps to the existing platform.

The project which is first open source edge computing initiative from Baidu and also one of the first in China will proliferate edge computing applications globally. The industry is undergoing a paradigm shift in computing infrastructure with news pouring in everyday about new developments in Artificial Intelligence and machine learning. As Industrial robotics, self-driving cars and smart gadgets become everyday reality, more and more computing is going to shift from cloud to the device edge. This has led many experts in the industry to suggest that edge computing is the next big thing.

Baidu has also significantly invested in other open source projects which include its autonomous driving platform Apollo and artificial intelligence framework PaddlePaddle. An agricultural technology company McFly has successfully used Baidu’s cloud platform to collect and process data about crops which helps it to lower pesticide usage.

Other platforms in the industry which offers edge computing solution include Microsoft’s Azure and Amazon Web Services. Although AWS offers edge computing solutions, it’s a closed source software which restricts freedom of the developer.

UC Berkeley Research Team Tests Device which Acts as Sponge for Absorbing Excess Chemotherapy Drugs in the Bloodstream

A new device developed by University of California Berkeley, can be potentially used for absorbing excess chemotherapy drugs before they circulate in the bloodstream. This has shown potential to significantly reduce side effects of the chemo drugs for patients undergoing the treatment.

Chemotherapy is a part of the standard treatment procedure for diagnosed cancers. While it attacks the tumor and stops its further growth, but it also causes a great collateral damage to healthy tissues in the body as well. Oncologists and radiologists agree that chemotherapy is not exactly the most effective therapy in cancer treatment but lack of alternatives has made it the only viable option right now. Chemotherapy is riddled with massive side effects including anaemia, dysfunctional immune system, hair loss, nausea and vomiting. Although it manages to kill cancerous cells but studies have suggested that 50-80 % of chemo drugs don’t even reach the tumor and instead circulates in the bloodstream causing damage to healthy cells.

The new device developed by a team of researchers at UC Berkeley, will act as ‘sponge’ which will absorb excess chemo drugs from the bloodstream. Professor Nitash Balsara, the head of UCB’s team, said that the device is inspired by absorbers used in petroleum refining, which regularly uses absorbers to remove unwanted chemicals like sulphur. The team created 3D printed tiny cylinders, 3mm long made from poly diacrylate (ethylene glycol), with a square lattice structure inside which allows blood vessels to pass through it. But the lattice structure is coated with copolymer which attaches itself to the chemo dug and stops its passage. The device shows promises to bring down side effects of chemotherapy and opens doors for increased chemo dosage for the patients in need of it.

Doxorubicin, with brand name Adriamycin is a chemotherapy drug used for many types of cancer. The team used this drug for testing on three pigs and found that when the drug was injected in a particular vein, it flew through the bloodstream and was detected by the device. 64% of the drug was captured by the device. Prof. Balsara said that the team considered all the risk factors like thrombosis or blood clotting while developing the device and issues related to vein wall dissection and blood clots were not observed.

Cancer researchers have long been looking for good alternatives for chemotherapy, while some breakthroughs in targeted medicine which selectively kills only cancerous cells excluding the healthy ones has made much headway. But chemotherapy is going to hang around for a while. The new device offers hope for 650,000 cancer patients in USA and millions worldwide who undergo chemotherapy every year. Although much work remains to be done before the device’s roll out in hospitals the study has shown hope to reduce side effects of drugs and scope for regionally targeted high dose chemotherapy.

Lack of Deep Sleep Linked to Early Signs of Alzheimer’s Disease

In a new study, researchers at Washington University School of Medicine in St. Louis may have uncovered important explanation on how and why poor sleep is linked to early signs of Alzheimer’s disease.

Older people who have reduced slow-wave sleep – the deep sleep required to accumulate memories and wake up feeling refreshed – tend to have higher percentage of the brain protein tau, according to the researchers. Elevated tau has not only been associated with memory loss, confusion, and brain damage but also been considered as a sign of Alzheimer’s disease.

Findings of the study, appeared recently in Science Transitional Medicine, suggest that poor-quality sleep in later life could a warning sign of deteriorating brain health.

Most interestingly, the team observed an inverse relationship between reduced slow-wave sleep and increased tau protein in people who were cognitively normal or mildly impaired, indicating that decreased slow-wave sleep could be a marker for the transition from normal cognition to impaired one.

According to Brendan Lucey, MD, first author and assistant professor of neurology, measuring the way people sleep would be a noninvasive method to check for Alzheimer’s disease before and as the people start to have issues with memory and thinking.

Changes in the brain that lead to Alzheimer’s disease, affecting an estimated 5.7 million US population, begin slowly and silently. Up to two decades, amyloid beta proteins begin to consolidate into plaques in the brain, before the distinctive symptoms of confusion and memory loss appear. Tau proteins tangled up much later, followed by deterioration of key brain regions. Only then do people start showing the critical symptoms of cognitive decline.

It has been a challenge detect people who are likely to develop Alzheimer’s, prior to changes in the brain that limits the ability to think clearly.

For better understanding of the relationship between sleep and Alzheimer’s disease, the team examined 119 study participants 60 years of age or above. Of which, around 80% were cognitively normal, while the remaining ones were very mildly impaired.

The researchers monitored the volunteers’ sleep at home over the course of a normal week. To measure the brain waves, the participants were provided a portable EEG monitor strapped on their foreheads and for wristwatch-like sensor for tracking the body movement. Additionally, they kept a sleep log, noting down nighttime sleep sessions as well as daytime napping.

The researchers also measured levels of tau protein and amyloid beta in the brain and in the cerebrospinal fluid. Of all the participants, 38 underwent brain PET scan for the two proteins, 104 underwent spinal taps, and 27 did both.

After controlling for different factors such as age, sex, and sleep movements, the researchers discovered that reduced slow-wave sleep associated with elevated tau in the brain and a high ratio of tau-to-amyloid in the cerebrospinal fluid.

Lucey said that the important observation is that the total amount of sleep was not linked to tau, but rather the slow-wave sleep, reflecting the quality of sleep. If future research confirms their results, sleep monitoring may contribute as a simple and affordable way to screen earlier of Alzheimer’s disease, the researchers said.

Plant-based-meat and Gluten Free Burger Impossible Burger 2.0 Backed by Bill Gates Debuts at CES 2019 Las Vegas

Bill Gates backed food startup Impossible Foods have debuted the upgraded version of their plant based healthy burger named Impossible Burger 2.0 at the Burger Grill at Las Vegas CES 2019.

The updated Impossible Burger 2.0 contains zero milligrams cholesterol, 14 grams fat and 250 calories in quarter pound patty. The company said that the fans of the previous version of Impossible Burger wanted a wheat or gluten free burger. The updated version of the burger has instead used soya based protein for its burger instead of wheat protein. The new burger is a significant improvement from the previous burger as it was only meant for cooking in restaurants while the 2.0 version can be cooked at home by sizzling on open flame, steaming and searing. The burger makes no compromise with nutrition or taste as it tastes the same like meat burger while at the same time containing the same nutritional content that you get from a beef burger. The burger has strange component called leghemoglobin or heme which gives the burger a bleeding attribute along with adding to the flavor of the final product.

The burger prides at being environmentally sustainable with 87% less greenhouse gas emissions, 75% lesser water and 95% lesser land than the regular ground beef burger. Food sector has seen some groundbreaking sustainable innovations in the recent decades. As plant based diet and vegan movements have propelled the demand for healthy food, food companies are left with no choice but to innovate in creating eco-friendly food recipes. Owner of Border Grill, the restaurant chosen for the debut, Sue Milliken said that using animals to meet human protein needs is going to be thing of the past with many healthy and delicious plant based alternatives arriving in the market. Finally technology has given solutions to meat lovers to satiate their taste buds without any harm to biodiversity.

White Castle has bagged the status of being the first fast-food burger chain to debut the Impossible Burger 2.0 at its restaurant starting with Border Grill, Las Vegas. The burger apart from being covered in stories by all major newspapers has become a latest Twitter sensation with a trending hashtag and also taken Instagram by a whirlwind. Whalburger and Umami Burgers are next in line to launch the new burger on their menu in next couple of weeks. The company will initially launch the burger only in handful of private burger chains with plans to a nationwide launch soon.

Impossible Foods production unit in Oakland, Caliph is spread over 68,000 Sq. ft. The company is facing tough competition from other health food startups like Tyson Food backed Beyond Burger. Many large food companies are launching new plant based food products. Nestle has recently launched its Incredible Burger under Garden Gourmet brand name with recent news reporting that Unilever’s acquisition of a Dutch plant based meat company Vegetarian Butcher.

TrAPs, a New Material Developed by British Scientists Paves Way for Accelerated Tissue Regeneration

A team of scientists from Imperial College London has developed a bio-inspired material which will help in accelerating healing process in human body. The rate of wound self-healing itself plays critical role in certain situations as a speedier recovery could help save lives. Dr. Ben Almquest heading the team of scientist at Imperial College is working towards accelerating the healing process through use of biomaterials.

The new material called Traction force Activated Payloads or TrAPs is specially developed to interact with and augment the healing process in the human body.  The team is currently looking to adopt this material in traditionally used materials which help with healing and tissue regeneration. In case of chronic wounds, in addition to body’s natural ability to self-heal, an accelerated healing rate is needed. TrAPs precisely helps in this by adopting to the body’s needs.

Whenever the body experiences a wound, there occurs a formation of thin layer of collagen. The cells pass through this thin layer of collagen and bring with them a thread of proteins. These healthy proteins are responsible for cell regeneration and activation of the healing process. But these proteins are not enough for accelerated growth of tissues. Scientists found that if they could somehow manage a long thread of proteins at this stage, there would be rapid healing.

What the new material promises to do is mimic this healing action accelerating the natural process exponentially. The technique used by this material uses Aptamers. Aptamers are folded DNA segments, researchers used these aptamers so that proteins could be attached throughout its many folds. A handle is attached to one side the DNA string while a collagen layer is attached to the other end. When the cells thorough the natural process of cell regeneration, moves through the thin collagen layer on top of the wound, they bring TrAPs with them which unravels the Aptamers and huge number of proteins along with it on the wound. The process thus augments cell regeneration.

The technique has unraveled new potential to deliver tailored for specific types of cells. Doctors can now select a particular aptamer for a particular cell type along with ability to pull different aptamer at different stage of cell repair. This ability of using cell movement to trigger healing process is observed in many creatures including humans and sea sponges. The new approach mimics this process which offers flexibility to interact with different types of cells in the damaged tissue.

The applications of this approach is fascinating with potential adoptions in repairing nerve damage, scar tissue which occurs after heart attack and also fractured bones. The key feature is that TrAPs are easy to create in laboratories and can be produced on an industrial scale. Its dynamic and intelligent healing which actively communicates with the wound has shown hope for healing many chronic wounds including diabetic foot ulcers which is a leading cause of leg amputations.

Ford Motor Company to Lay off Thousands of Workers as Part of Major Restructuring and Shift to Electric Vehicles

Ford is reportedly laying of thousands of workers from its payroll in Europe as it kick starts a major restructuring in the company to evolve better and profitable model in an industry increasingly leaning towards e-mobility. The company in the recent statement said that surplus labor will be reduced to undertake structural cost adjustments. It is also planning to close some plants in near future.

The company based in Dearborn, Michigan employees over 53,000 workers in its European production facility located at Cologne, Germany. The company in the statement did not disclose the exact number of job cuts but said that the company will negotiate with employee representatives and unions to ensure that voluntary departures occur.  The move comes after the company announced in 2018 to reduce white collar jobs across the global expanse of the company.

The company is shifting to electric vehicles and is working out a more profitable business model. Every model form now onwards will have a battery version, with some dual models having both battery and internal combustion. Steven Armstrong, the company’s vice president of Europe, Africa and Middle East said that as Ford continues transition to e-mobility based model, it will optimize its human resources to look for more profitable models and by exiting from the less profitable ones.

Global automotive giants are facing challenges from a move towards autonomous and battery powered vehicles as well as transportation service providers like car-sharing and ride-hailing smartphone apps. Consumers are also leaning towards sport utility vehicles from the earlier preferences like hatchbacks and sedans. Ford has also remodeled its global operations buy exiting from sedan business in USA. Traditional automakers are forced to grapple with ground breaking technology changes, trade tensions and stricter environmental regulations.

The trend is not just limited to Ford Motor Company. The global slowdown in car sales is also seen in China which historically is a major contributor in fueling the industry’s growth. Auto sales in China fell for the first time in last two decades, this has raised concerns in the industry as well as markets.

General Motors in November 2018 announced that it would cut 14,000 white collar and factory jobs from its North American business, and has put five plant closures in waiting. Volkswagen reported an unspecified number of cuts in jobs as it moves towards electric car production. BBC reported that 5000 job reductions are expected by Tata Motors Ltd.

Pfizer Plans to Shut down Two Manufacturing Plants in India

American drugmaker Pfizer announced on Wednesday it will soon be shutting down two of its manufacturing plants in India that make generic injectable drugs, in response to falling demand.

As reported in Reuters, the two sites in the states of Maharashtra and Tamil Nadu employ nearly 1,700 workers, contributing around 6 percent to Pfizer’s global manufacturing workforce.

After conducting a thorough evaluation of both the plant, Pfizer has come into conclusion that manufacturing at these sites is not viable because of significant long term loss of product, the company wrote in an emailed statement.

Both the sites are export-oriented and came under the company’s ownership when it purchased Hospira Inc in a $15 billion deal in February 2015, with an objective to boost its portfolio of generic injectables as well as copies of biotech medicines.

Pfizer is also reportedly shutting down a Hospira research and development lab in Chennai, India. However, Steven Danehy, Pfizer spokesman said that it was concerned with the shutdown of its two big sites. Nearly 150 workers at that facility were informed about the shutdown in the last quarter of 2018, he added.

Pfizer’s Chennai site manufactures generic injectable drugs of penicillin, penems, and cephalosporin, while the plant in Maharashtra supplied the Chennai unit with various products.

The company said that these plants do not manufacture products for the Indian market, adding an expansion to its operations in Visakhapatnam unit in South India, to bring it up as global terminally sterilized manufacturing center of excellence.

Pfizer had suspended manufacturing at the Chennai facility as it received several observations from the US Food and Drug Administration (US FDA), the latest being 11 observations in March-April last year.

Following the closure of these two sites, Pfizer will be left with manufacturing plants in Visakhapatnam, Goa, and a joint venture site – Zydus Hospira Oncology Pvt Ltd (ZHOPL) – formed to make injectable cytotoxic drugs in Ahmedabad, Gujarat.

While exact timing of the shutdown of the two sites is not yet determined, Pfizer said that the announcement does not directly impact operations at other sites.